Pilot of a Computerised Antithrombotic Risk Assessment Tool Version 2 (CARATV2. 0) for stroke prevention in atrial fibrillation
Y Wang, B Bajorek - Cardiology Journal, 2017 - journals.viamedica.pl
Background: The decision-making process for stroke prevention in atrial fibrillation (AF)
requires a comprehensive assessment of risk vs. benefit and an appropriate selection of …
requires a comprehensive assessment of risk vs. benefit and an appropriate selection of …
Pilot of a Computerised Antithrombotic Risk Assessment Tool Version 2 (CARATV2. 0) for stroke prevention in atrial fibrillation
Y Wang, B Bajorek - Cardiology Journal, 2017 - journals.viamedica.pl
Background: The decision-making process for stroke prevention in atrial fibrillation (AF)
requires a comprehensive assessment of risk vs. benefit and an appropriate selection of …
requires a comprehensive assessment of risk vs. benefit and an appropriate selection of …
Pilot of a Computerised Antithrombotic Risk Assessment Tool Version 2 (CARATV2. 0) for stroke prevention in atrial fibrillation
Y Wang, B Bajorek - Cardiology Journal, 2017 - search.proquest.com
BACKGROUND: The decision-making process for stroke prevention in atrial fibrillation (AF)
requires a comprehensive assessment of risk vs. benefit and an appropriate selection of …
requires a comprehensive assessment of risk vs. benefit and an appropriate selection of …
Pilot of a Computerised Antithrombotic Risk Assessment Tool Version 2 (CARATV2. 0) for stroke prevention in atrial fibrillation
Y Wang, B Bajorek - Cardiology journal, 2017 - pubmed.ncbi.nlm.nih.gov
Background The decision-making process for stroke prevention in atrial fibrillation (AF)
requires a comprehensive assessment of risk vs. benefit and an appropriate selection of …
requires a comprehensive assessment of risk vs. benefit and an appropriate selection of …
[PDF][PDF] Pilot of a Computerised Antithrombotic Risk Assessment Tool Version 2 (CARATV2. 0) for stroke prevention in atrial fibrillation
Y Wang, B Bajorek - CLINICAL CARDIOLOGY, 2017 - core.ac.uk
Background: The decision-making process for stroke prevention in atrial fibrillation (AF)
requires a comprehensive assessment of risk vs. benefit and an appropriate selection of …
requires a comprehensive assessment of risk vs. benefit and an appropriate selection of …
[PDF][PDF] Pilot of a Computerised Antithrombotic Risk Assessment Tool Version 2 (CARATV2. 0) for stroke prevention in atrial fibrillation
Y Wang, B Bajorek - CLINICAL CARDIOLOGY, 2017 - pdfs.semanticscholar.org
Background: The decision-making process for stroke prevention in atrial fibrillation (AF)
requires a comprehensive assessment of risk vs. benefit and an appropriate selection of …
requires a comprehensive assessment of risk vs. benefit and an appropriate selection of …
Pilot of a Computerised Antithrombotic Risk Assessment Tool Version 2 (CARATV2. 0) for stroke prevention in atrial fibrillation.
Y Wang, B Bajorek - Cardiology Journal, 2017 - europepmc.org
Background The decision-making process for stroke prevention in atrial fibrillation (AF)
requires a comprehensive assessment of risk vs. benefit and an appropriate selection of …
requires a comprehensive assessment of risk vs. benefit and an appropriate selection of …
Pilot of a computerised antithrombotic risk assessment tool version 2 (CARATV2. 0) for stroke prevention in atrial fibrillation
Y Wang, B Bajorek - Cardiology Journal, 2017 - opus.lib.uts.edu.au
© 2017 Via Medica. Background: The decision-making process for stroke prevention in atrial
fibrillation (AF) requires a comprehensive assessment of risk vs. benefit and an appropriate …
fibrillation (AF) requires a comprehensive assessment of risk vs. benefit and an appropriate …